Total Payments
$22,968
2024 Payments
$7,617
Companies
68
Transactions
715
Medicare Patients
678
Medicare Billing
$51,511
Payment Breakdown by Category
Food & Beverage$20,051 (87.3%)
Other$1,498 (6.5%)
Education$1,419 (6.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,051 | 681 | 87.3% |
| Long term medical supply or device loan | $1,498 | 17 | 6.5% |
| Education | $1,419 | 17 | 6.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,437 | 70 | $0 (2024) |
| Janssen Biotech, Inc. | $1,805 | 53 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,498 | 40 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,426 | 31 | $0 (2024) |
| Celgene Corporation | $1,161 | 44 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,149 | 43 | $0 (2024) |
| ABBVIE INC. | $944.34 | 21 | $0 (2024) |
| Eisai Inc. | $884.38 | 25 | $0 (2024) |
| Astellas Pharma US Inc | $775.12 | 22 | $0 (2024) |
| GlaxoSmithKline, LLC. | $764.54 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,617 | 225 | Novartis Pharmaceuticals Corporation ($1,487) |
| 2023 | $6,950 | 239 | E.R. Squibb & Sons, L.L.C. ($565.12) |
| 2022 | $6,530 | 193 | Janssen Biotech, Inc. ($576.36) |
| 2021 | $1,871 | 58 | GlaxoSmithKline, LLC. ($296.31) |
All Payment Transactions
715 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Oncology | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $89.07 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Oncology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $13.07 | General |
| Category: Oncology | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $26.84 | General |
| Category: Oncology | ||||||
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $24.22 | General |
| Category: Oncology | ||||||
| 11/26/2024 | Apellis Pharmaceuticals, Inc. | Empaveli (Drug) | Food and Beverage | In-kind items and services | $31.52 | General |
| Category: Hematology | ||||||
| 11/22/2024 | Alnylam Pharmaceuticals Inc. | GIVLAARI (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Genetic Disease | ||||||
| 11/22/2024 | SpringWorks Therapeutics, Inc. | OGSIVEO (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: DESMOID TUMORS | ||||||
| 11/20/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Oncology | ||||||
| 11/20/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/18/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $17.10 | General |
| Category: Hematology/Oncology | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $81.89 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Long term medical supply or device loan | In-kind items and services | $83.33 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: Immunology | ||||||
| 11/13/2024 | Janssen Pharmaceuticals, Inc | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $122.28 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Oncology | ||||||
| 11/05/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/01/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 239 | 285 | $88,820 | $17,499 |
| 2022 | 4 | 295 | 364 | $113,860 | $24,496 |
| 2021 | 3 | 144 | 153 | $40,055 | $9,516 |
Total Patients
678
Total Services
802
Medicare Billing
$51,511
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 148 | 179 | $50,302 | $10,452 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 91 | $35,938 | $6,542 | 18.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $2,580 | $505.05 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 162 | 209 | $57,471 | $12,397 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 95 | $36,856 | $7,614 | 20.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $13,017 | $2,995 | 23.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 34 | 38 | $6,516 | $1,491 | 22.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 88 | 96 | $25,655 | $6,062 | 23.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 23 | $8,742 | $2,105 | 24.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 34 | 34 | $5,658 | $1,349 | 23.9% |
About Afton Dickerson, NP
Afton Dickerson, NP is a Acute Care healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2020. The National Provider Identifier (NPI) number assigned to this provider is 1497387393.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Afton Dickerson, NP has received a total of $22,968 in payments from pharmaceutical and medical device companies, with $7,617 received in 2024. These payments were reported across 715 transactions from 68 companies. The most common payment nature is "Food and Beverage" ($20,051).
As a Medicare-enrolled provider, Dickerson has provided services to 678 Medicare beneficiaries, totaling 802 services with total Medicare billing of $51,511. Data is available for 3 years (2021–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Houston, TX
- Active Since 02/07/2020
- Last Updated 11/04/2025
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1497387393
Products in Payments
- KISQALI (Drug) $1,492
- KEYTRUDA (Biological) $1,113
- Pomalyst (Drug) $1,109
- Lenvima (Drug) $884.38
- DARZALEX (Biological) $878.72
- IMBRUVICA (Drug) $728.10
- VENCLEXTA (Drug) $715.49
- LYNPARZA (Drug) $662.91
- REBLOZYL (Biological) $660.09
- MONJUVI (Drug) $611.65
- OPDIVO (Biological) $503.04
- JEVTANA (Drug) $484.12
- ZEJULA (Drug) $387.21
- ERLEADA (Drug) $352.02
- VERZENIO (Drug) $343.72
- ENHERTU (Biological) $310.06
- OPDUALAG (Drug) $309.67
- LIBTAYO (Biological) $295.15
- QINLOCK (Drug) $294.28
- Fabhalta (Drug) $246.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Houston
Michelle Johnston, Acnp, ACNP
Acute Care — Payments: $14,879
Acute Care $14,879
Amanda Bergeron, Agacnp, AGACNP
Acute Care — Payments: $11,628
Acute Care $11,628
Nicole Ona, Agacnp-Bc, AGACNP-BC
Acute Care — Payments: $10,247
Acute Care $10,247
Miss. Brittney Richard, Acnp, ACNP
Acute Care — Payments: $9,804
Acute Care $9,804
Meagan Chavarria, Np, NP
Acute Care — Payments: $8,988
Acute Care $8,988
Mrs. Laura Wueste, Rn, Msn, Acnp-Bc, RN, MSN, ACNP-BC
Acute Care — Payments: $8,184
Acute Care $8,184